Although the treatment of myocardial infarction (MI) has improved considerably, it is still a
worldwide disease with high morbidity and high mortality. Whilst there is still a long way to …

Acute myocardial infarction (MI) inflicts massive injury to the coronary microcirculation
leading to vascular disintegration and capillary rarefication in the infarct region. Tissue …

The onset of heart failure is typically preceded by cardiac hypertrophy, a response of the
heart to increased workload, a cardiac insult such as a heart attack or genetic mutation …

Myocardial infarction (MI) leads to the mass death of cardiomyocytes accompanying with the
unfavorable alternation of microenvironment, a fibrosis scar deprived of electrical …

The clinical translation of messengerRNA (mRNA) drugs has been slowed by a shortage of
delivery vehicles that potently and safely shuttle mRNA into target cells. Here, we describe …

For the past decades, heart diseases remain the leading cause of death worldwide. In the
adult mammalian heart, damaged cardiomyocytes will be replaced by non-contractile fibrotic …

Ischemic heart disease is a leading cause of death worldwide. After the onset of myocardial
infarction, many pathological changes take place and progress the disease towards heart …

Because of cardiomyocyte death or dysfunction frequently caused by myocardial infarction
(MI), heart failure is a leading cause of morbidity and mortality in modern society …

Myocardial infarction is the most significant manifestation of ischemic heart disease and is
associated with high morbidity and mortality. Novel strategies targeting at regenerating the …

The medical device industry is growing at a very fast pace and has recorded great research
activity over the past decade. The interdisciplinary nature of this field has made it possible …